health
Study identifies B cells as drivers of immunotherapy-related colitis
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
New test in Nottingham diagnoses MS without needle procedure
BBC
Devon and Cornwall families plea for more help in dementia battle
BBC
Middlesbrough FC Foundation cancer fitness group 'saved me'
BBC
Girl,12, campaigns for healthier hospital food
BBC
'A bleak picture': The Plymouth wards where men are facing premature death
Plymouth Live